Back to Search Start Over

Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L

Details

ISSN :
01695002
Volume :
165
Database :
OpenAIRE
Journal :
Lung Cancer
Accession number :
edsair.doi...........660ba3e0f86a2ca60f76bd5d6440094c
Full Text :
https://doi.org/10.1016/s0169-5002(22)00107-6